AbbVie Inc.
Explore AbbVie
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
AbbVie Inc.
Explore AbbVie
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2021 Revenue
$56.2B
▲ 22.7% vs FY2020 ($45.8B)
Source: Annual report / company filing
AbbVie Inc. reported $56.2B in revenue for fiscal year 2021. This represents a growth of 22.7% compared to the 2020 figure of $45.8B. In 2022, revenue increased to $58.1B.
A 23% jump on the first full year of Allergan plus peak Humira sales.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $61.2B | $4.3B | +8.6% |
| FY2024 | $56.3B | — | +3.6% |
| FY2023 | $54.3B | — | -6.4% |
| FY2022 | $58.1B | — | +3.3% |
| FY2021 | $56.2B | — | +22.7% |
| FY2020 | $45.8B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.